Optimization of transfection mediated by calcium phosphate for plasmid rAAV-LacZ (recombinant adeno-associated virus-β-galactosidase reporter gene) production in suspension-cultured HEK-293 (human embryonic kidney 293) cells

被引:12
作者
Feng, Lei [1 ]
Guo, Meijin [1 ]
Zhang, Shuxiang [1 ]
Chu, Ju [1 ]
Zhuang, Yingping [1 ]
Zhang, Siliang [1 ]
机构
[1] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China
关键词
calcium phosphate (CaPi); cell aggregation; ethylene glycol tetra-acetic acid (EGTA); human embryonic kidney (HEK-293 cells); recombinant adeno-associated virus (rAAV); transfection complex;
D O I
10.1042/BA20060143
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
rAAV (recombinant adeno-associated virus) has become a very useful gene-delivery vector for gene there apy. However, it is very difficult to generate rAAV using triple transfection on a commercial scale, owing to its low productivity and inconveniently adhesive nature of its culture. An optimal suspension-culture transfection procedure was developed for rAAV-LacZ production in suspended HEK-293 cells mediated by calcium phosphate (IacZ, a reporter gene, codes for beta-galactosidase). The study showed that cytotoxicity of transfection complexes and cell aggregation in suspension culture were two key factors affecting high suspension-culture transfection efficiency. Cytotoxicity of transfection complexes was influenced effectively by mixture of Ca2+ and plasmid DNA when their concentrations were decreased from 300 to 150 mM and from 3.0 to 1.5 mu g/ml respectively, as manifested by a relatively higher cell viability after suspension-culture transfection. Moreover, the transfection efficiency was still less than 15%. In addition, we explored the disruption of cell aggregation and the control of transfectioncomplex size with 2.0 mM EGTA treatment for 30 min before transfection and the addition of 100 mM Mg2+ during transfection respectively, procedures which enhanced transfection efficiency significantly, owing to more contact and endocytosis between cells and transfection complexes. Finally, the high transfection level and rAAV-LacZ titre achieved under optimized suspension-culture transfection conditions, namely 40% and 5 x 10" v.g. (vector genomes)/60 ml of medium respectively, is promising for the technique's application in the large-scale production of rAAV.
引用
收藏
页码:127 / 135
页数:9
相关论文
共 38 条
[1]   Improving rAAV production and purification: towards the definition of a scaleable process [J].
Blouin, V ;
Brument, N ;
Toublanc, E ;
Raimbaud, I ;
Moullier, P ;
Salvetti, A .
JOURNAL OF GENE MEDICINE, 2004, 6 :S223-S228
[2]   Adeno-associated virus and the development of adeno-associated virus vectors: A historical perspective [J].
Carter, BJ .
MOLECULAR THERAPY, 2004, 10 (06) :981-989
[3]   Dramatic effect of Mg2+ on transfecting mammalian cells by DNA/calcium phosphate precipitates [J].
Chowdhury, EH ;
Megumi, K ;
Harada, I ;
Kundu, AK ;
Akaike, T .
ANALYTICAL BIOCHEMISTRY, 2004, 328 (01) :96-97
[4]   Transfecting mammalian cells by DNA/calcium phosphate precipitates: Effect of temperature and pH on precipitation [J].
Chowdhury, EH ;
Sasagawa, T ;
Nagaoka, M ;
Kundu, AK ;
Akaike, T .
ANALYTICAL BIOCHEMISTRY, 2003, 314 (02) :316-318
[5]   Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle [J].
Clark, KR ;
Sferra, TJ ;
Johnson, PR .
HUMAN GENE THERAPY, 1997, 8 (06) :659-669
[6]  
Drittanti L, 2001, J GENE MED, V3, P59, DOI 10.1002/1521-2254(2000)9999:9999<::AID-JGM152>3.0.CO
[7]  
2-U
[8]   Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors [J].
Farson, D ;
Harding, TC ;
Tao, L ;
Liu, J ;
Powell, S ;
Vimal, V ;
Yendluri, S ;
Koprivnikar, K ;
Ho, K ;
Twitty, C ;
Husak, P ;
Lin, A ;
Snyder, RO ;
Donahue, BA .
JOURNAL OF GENE MEDICINE, 2004, 6 (12) :1369-1381
[9]   Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis [J].
Fisher, KJ ;
Gao, GP ;
Weitzman, MD ;
DeMatteo, R ;
Burda, JF ;
Wilson, JM .
JOURNAL OF VIROLOGY, 1996, 70 (01) :520-532
[10]   Gene therapy progress and prospects: Recombinant adeno-associated virus (rAAV) vectors [J].
Flotte, TR .
GENE THERAPY, 2004, 11 (10) :805-810